PI3 kinase as a therapeutic target for diseases associated with mutations in the catalytic domain of Kit.

被引：0
|
作者：
Linnekin, D [1 ]
Krupa, S [1 ]
机构：
[1] NCI, Frederick Canc Res Facil, Basic Res Lab, Frederick, MD USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
712
引用
收藏
页码：190A / 190A
页数：1
相关论文
共 50 条
  • [21] PI3 kinase mediates transformation of hematopoietic cells by THF V816 c-Kit mutant.
    Linnekin, D
    Young, S
    Danilkovitch-Miagkova, A
    Ronnstrand, L
    Leonard, E
    Ferrao, P
    Ashman, L
    Chian, RJ
    BLOOD, 2000, 96 (11) : 498A - 498A
  • [22] Binding specificity of PI3 kinase C-SH2 domain as revealed by a combinatorial library approach
    Abugosh, Wasseem
    Pei, Dehua
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237 : 416 - 416
  • [23] Inactivation of catalytic and non-catalytic PI3 kinase gamma functions enhances hypoxia-induced pulmonary hypertension in mice
    Gnatzy-Feik, L.
    Berghausen, E.
    Vantler, M.
    Mueller, R.
    Zierden, M.
    Ghigo, A.
    Hirsch, E.
    Baldus, S.
    Rosenkranz, S.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1931 - 1931
  • [24] Phosphatidylinositol 3′-kinase is required for growth of mast cells expressing the Kit catalytic domain mutant
    Shivakrupa, R
    Bernstein, A
    Watring, N
    Linnekin, D
    CANCER RESEARCH, 2003, 63 (15) : 4412 - 4419
  • [25] PI3KCA mutations in advanced urothelial carcinoma: A potential therapeutic target?
    Molins, Joaquim Bellmunt
    Werner, Lillian
    Guix, Marta
    Guancial, Elizabeth Ann
    Schutz, Fabio Augusto Barros
    O'Brien, Robert
    Stack, Edward C.
    Loda, Massimo F.
    Berman, David M.
    Hirsch, Michelle S.
    Signoretti, Sabina
    Gallardo, Enrique
    Rojo, Federico
    Ross, Robert W.
    Kantoff, Philip
    Choueiri, Toni K.
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Folding kinetics of the SH3 domain of PI3 kinase by real-time NMR combined with optical spectroscopy
    Guijarro, JI
    Morton, CJ
    Plaxco, KW
    Campbell, ID
    Dobson, CM
    JOURNAL OF MOLECULAR BIOLOGY, 1998, 276 (03) : 657 - 667
  • [27] PI3 kinase inhibitor PI828 uncouples aminergic GPCRs and Ca2+ mobilization irrespectively of its primary target
    Kotova, Polina D.
    Dymova, Ekaterina A.
    Lyamin, Oleg O.
    Rogachevskaja, Olga A.
    Kolesnikov, Stanislav S.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2024, 1868 (08):
  • [28] PI3 kinase isoform p110? is more important than p110? in KIT signaling in hematopoietic cells
    ZHANG, L. I. A. N. G. Y. I. N. G.
    ZHANG, S. H. A. O. T. I. N. G.
    FAN, Z. H. A. O. Y. A. N. G.
    JIANG, Z. O. N. G. Y. I. N. G.
    LIU, A. N. B. U.
    LI, S. H. U. J. I. N. G.
    SUN, J. I. A. N. M. I. N.
    BIOCELL, 2022, 46 (09) : 2081 - 2087
  • [29] Cell-permeable PI3 kinase competitive peptide inhibits KIT mutant mediated tumorigenesis of gastrointestinal stromal tumor (GIST)
    Jiang, Zongying
    Guo, Yue
    Shi, Jun
    Zhang, Shaoting
    Zhang, Liangying
    Wang, Yapeng
    Li, Guofu
    Bai, Ru
    Zhao, Hui
    Sun, Jianmin
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [30] Antioxidant responsive element activation by quinones: Antioxidant responsive element target genes, role of PI3 kinase in activation
    Li, J
    Lee, JM
    Johnson, DA
    Johnson, JA
    QUINONES AND QUINONE ENZYMES, PT A, 2004, 378 : 238 - 258
12345